hydroxyurea has been researched along with Dermatitis Medicamentosa in 50 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medication-induced dermatomyositis (DM) is rare, but a recent review highlighted hydroxyurea (HU) as the most common inciting agent." | 8.88 | Hydroxyurea induced dermatomyositis-like eruption. ( Muir, J; Rodins, K; Zappala, TM, 2012) |
| " Hydroxyurea-induced dermatomyositis is a rare adverse reaction of long-term hydroxyurea therapy." | 7.78 | Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption? ( El-Din, ES; Nofal, A, 2012) |
| "An elderly woman receiving chronic hydroxyurea therapy for myelodysplasia developed a dermatomyositis-like eruption that was misdiagnosed as true dermatomyositis, leading to continuation of hydroxyurea." | 7.76 | Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure. ( Burruss, JB; Callen, JP; Cely, SJ; Kalajian, AH; Malone, JC, 2010) |
| "A 68-year-old women with polycythemia vera was treated with hydroxyurea for 8 years and developed painful ulcers on her lower legs, multiple hypertrophic actinic keratoses and a squamous cell carcinoma." | 7.75 | [Cutaneous side effects of hydroxyurea treatment for polycythemia vera]. ( Akanay-Diesel, S; Hanneken, S; Hoff, NP; Pippirs, U; Schulte, KW, 2009) |
| "Hydroxyurea (HU) is usually a well-tolerated antineoplastic agent, which is commonly used in the treatment of myeloproliferative disorders." | 7.71 | [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders]. ( Olesen, LH; Pedersen, BB, 2001) |
| "We report the case of an elderly woman who had been on hydroxyurea for long-standing widespread psoriasis." | 7.70 | Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis. ( Lanigan, SW; Varma, S, 1999) |
| "Forty-one patients (mean age, 67 years) developed leg ulcerations while undergoing hydroxyurea therapy (mean therapy duration, 5 years)." | 7.70 | Leg ulcers and hydroxyurea: forty-one cases. ( Baudot, N; Beylot, C; Bonnetblanc, JM; Dandurand, M; Debure, C; Denoeux, JP; Dubertret, L; Frances, C; Gauthier, O; Guillot, B; Humbert, P; Lambert, D; Lok, C; Lorette, G; Loubeyres, S; Morel, P; Roux, ME; Sirieix, ME; Vaillant, L, 1999) |
| "Hydroxyurea is an anti-tumour agent most commonly used to treat chronic myeloproliferative disorders in doses up to 4 g per day." | 5.31 | Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. ( Kaur, I; Kumar, B; Saraswat, A, 2002) |
| "Medication-induced dermatomyositis (DM) is rare, but a recent review highlighted hydroxyurea (HU) as the most common inciting agent." | 4.88 | Hydroxyurea induced dermatomyositis-like eruption. ( Muir, J; Rodins, K; Zappala, TM, 2012) |
| " Hydroxyurea-induced dermatomyositis is a rare adverse reaction of long-term hydroxyurea therapy." | 3.78 | Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption? ( El-Din, ES; Nofal, A, 2012) |
| "An elderly woman receiving chronic hydroxyurea therapy for myelodysplasia developed a dermatomyositis-like eruption that was misdiagnosed as true dermatomyositis, leading to continuation of hydroxyurea." | 3.76 | Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure. ( Burruss, JB; Callen, JP; Cely, SJ; Kalajian, AH; Malone, JC, 2010) |
| "A 68-year-old women with polycythemia vera was treated with hydroxyurea for 8 years and developed painful ulcers on her lower legs, multiple hypertrophic actinic keratoses and a squamous cell carcinoma." | 3.75 | [Cutaneous side effects of hydroxyurea treatment for polycythemia vera]. ( Akanay-Diesel, S; Hanneken, S; Hoff, NP; Pippirs, U; Schulte, KW, 2009) |
| "Hydroxyurea (HU) is usually a well-tolerated antineoplastic agent, which is commonly used in the treatment of myeloproliferative disorders." | 3.71 | [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders]. ( Olesen, LH; Pedersen, BB, 2001) |
| "We report the case of an elderly woman who had been on hydroxyurea for long-standing widespread psoriasis." | 3.70 | Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis. ( Lanigan, SW; Varma, S, 1999) |
| "Forty-one patients (mean age, 67 years) developed leg ulcerations while undergoing hydroxyurea therapy (mean therapy duration, 5 years)." | 3.70 | Leg ulcers and hydroxyurea: forty-one cases. ( Baudot, N; Beylot, C; Bonnetblanc, JM; Dandurand, M; Debure, C; Denoeux, JP; Dubertret, L; Frances, C; Gauthier, O; Guillot, B; Humbert, P; Lambert, D; Lok, C; Lorette, G; Loubeyres, S; Morel, P; Roux, ME; Sirieix, ME; Vaillant, L, 1999) |
| "Hydroxyurea was stopped for medical reasons in 11 patients: 6 failures, 1 pregnancy, 1 cutaneous rash, 1 leg ulcer, 1 lupus." | 3.70 | Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease. ( Bachir, D; Bégué, P; Bernaudin, F; de Montalembert, M; Micheau, M; Thuret, I, 1999) |
| " Acral erythema is another cutaneous side effect that is relatively specific to chemotherapy and is often dose-related." | 2.42 | Mucocutaneous side effects of antineoplastic chemotherapy. ( Bessis, D; Dereure, O; Guillot, B, 2004) |
| "Hydroxyurea is a medication with many well-described cutaneous side effects, notably the dermatomyositis-like eruption known as hydroxyurea dermopathy." | 1.46 | A Cutaneous Lupus Erythematosus-Like Eruption Induced by Hydroxyurea. ( Mosser-Goldfarb, JL; Yanes, DA, 2017) |
| " However, no epidemiologic information about the occurrence of the most clinically significant HU-associated adverse events is yet available." | 1.38 | Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN. ( Antonioli, E; Baccarani, M; Barbui, T; Bertozzi, I; Bosi, A; Cacciola, E; Cacciola, R; Cazzola, M; De Stefano, V; Elli, E; Finazzi, G; Finazzi, M; Guglielmelli, P; Luigia Randi, M; Martinelli, V; Passamonti, F; Pieri, L; Pogliani, E; Rambaldi, A; Rodeghiero, F; Rossi, E; Ruggeri, M; Rumi, E; Vannucchi, AM; Vianelli, N; Za, T, 2012) |
| "Here we report two cases of squamous cell carcinoma of the skin, which appeared in the photo-exposed areas in two elderly patients treated for advanced chronic myeloid leukemia with imatinib." | 1.32 | Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment. ( Audring, H; Baskaynak, G; Dörken, B; Kreuzer, KA; le Coutre, P; Riess, H; Schwarz, M; Zuber, J, 2003) |
| "Hydroxyurea is an anti-tumour agent most commonly used to treat chronic myeloproliferative disorders in doses up to 4 g per day." | 1.31 | Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. ( Kaur, I; Kumar, B; Saraswat, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (12.00) | 18.7374 |
| 1990's | 13 (26.00) | 18.2507 |
| 2000's | 18 (36.00) | 29.6817 |
| 2010's | 11 (22.00) | 24.3611 |
| 2020's | 2 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michalak, J | 1 |
| Simman, R | 1 |
| Oostra, D | 1 |
| Subhadarshani, S | 1 |
| Min, S | 1 |
| Holloway, K | 1 |
| Steadmon, M | 1 |
| de Unamuno-Bustos, B | 1 |
| Ballester-Sánchez, R | 1 |
| Sabater Marco, V | 1 |
| Vilata-Corell, JJ | 1 |
| Matthews, AG | 1 |
| Wylie, G | 1 |
| Yanes, DA | 1 |
| Mosser-Goldfarb, JL | 1 |
| Hoff, NP | 1 |
| Akanay-Diesel, S | 1 |
| Pippirs, U | 1 |
| Schulte, KW | 1 |
| Hanneken, S | 1 |
| Janerowicz, D | 1 |
| Czarnecka-Operacz, M | 1 |
| Stawny, M | 1 |
| Silny, W | 1 |
| Kalajian, AH | 1 |
| Cely, SJ | 1 |
| Malone, JC | 1 |
| Burruss, JB | 1 |
| Callen, JP | 1 |
| Kluger, N | 1 |
| Naud, M | 1 |
| Françès, P | 1 |
| Serrano-Falcón, C | 1 |
| Pugnaire, MAF | 1 |
| Del Mar Serrano-Falcón, M | 1 |
| Morales, MG | 1 |
| Serrano-Ortega, S | 1 |
| García-Martínez, FJ | 1 |
| García-Gavín, J | 1 |
| Alvarez-Pérez, A | 1 |
| Alonso-González, J | 1 |
| Ginarte, M | 1 |
| Toribio, J | 2 |
| Antonioli, E | 1 |
| Guglielmelli, P | 1 |
| Pieri, L | 1 |
| Finazzi, M | 1 |
| Rumi, E | 1 |
| Martinelli, V | 1 |
| Vianelli, N | 1 |
| Luigia Randi, M | 1 |
| Bertozzi, I | 1 |
| De Stefano, V | 1 |
| Za, T | 1 |
| Rossi, E | 1 |
| Ruggeri, M | 1 |
| Elli, E | 1 |
| Cacciola, R | 1 |
| Cacciola, E | 1 |
| Pogliani, E | 1 |
| Rodeghiero, F | 1 |
| Baccarani, M | 1 |
| Passamonti, F | 1 |
| Finazzi, G | 1 |
| Rambaldi, A | 1 |
| Bosi, A | 1 |
| Cazzola, M | 1 |
| Barbui, T | 1 |
| Vannucchi, AM | 1 |
| Nofal, A | 1 |
| El-Din, ES | 1 |
| Zappala, TM | 1 |
| Rodins, K | 1 |
| Muir, J | 1 |
| Hagen, JW | 1 |
| Magro, CM | 1 |
| Crowson, AN | 1 |
| Remlinger, KA | 1 |
| Aragane, Y | 1 |
| Okamoto, T | 1 |
| Yajima, A | 1 |
| Isogai, R | 1 |
| Kawada, A | 1 |
| Tezuka, T | 1 |
| Baskaynak, G | 1 |
| Kreuzer, KA | 1 |
| Schwarz, M | 1 |
| Zuber, J | 1 |
| Audring, H | 1 |
| Riess, H | 1 |
| Dörken, B | 1 |
| le Coutre, P | 1 |
| Oh, ST | 1 |
| Lee, DW | 1 |
| Lee, JY | 1 |
| Cho, BK | 1 |
| Geraminejad, PA | 1 |
| Walling, HW | 1 |
| Swick, BL | 1 |
| Sontheimer, RD | 1 |
| Guillot, B | 2 |
| Bessis, D | 1 |
| Dereure, O | 1 |
| Yoshida, K | 1 |
| Saito, M | 1 |
| Amagai, M | 1 |
| Ikeda, Y | 1 |
| Elliott, R | 1 |
| Davies, M | 1 |
| Harmse, D | 1 |
| Zaccaria, E | 1 |
| Cozzani, E | 1 |
| Parodi, A | 1 |
| León-Mateos, A | 1 |
| Zulaica, A | 1 |
| Caeiro, JL | 1 |
| Fabeiro, JM | 1 |
| Calviño, S | 1 |
| Peteiro, C | 1 |
| Sigal, M | 1 |
| Crickx, B | 1 |
| Blanchet, P | 1 |
| Perron, J | 1 |
| Simony, J | 1 |
| Belaïch, S | 1 |
| Burns, DA | 1 |
| Sarkany, I | 1 |
| Gaylarde, P | 1 |
| Kelly, RI | 1 |
| Bull, RH | 1 |
| Marsden, A | 1 |
| Brincker, H | 1 |
| Christensen, BE | 1 |
| Senet, P | 1 |
| Aractingi, S | 1 |
| Porneuf, M | 1 |
| Perrin, P | 1 |
| Duterque, M | 1 |
| Mounier, N | 1 |
| Farge, D | 1 |
| Lebbe, C | 1 |
| Marjanovic, Z | 1 |
| De Kerviler, E | 1 |
| Najean, Y | 1 |
| Rouffy, J | 1 |
| Bahadoran, P | 1 |
| Castanet, J | 1 |
| Lacour, JP | 1 |
| Perrin, C | 1 |
| Del Giudice, P | 1 |
| Mannocci, N | 1 |
| Fuzibet, JG | 1 |
| Ortonne, JP | 1 |
| Vélez, A | 1 |
| López-Rubio, F | 1 |
| Moreno, JC | 1 |
| Suehiro, M | 1 |
| Kishimoto, S | 1 |
| Wakabayashi, T | 1 |
| Ikeuchi, A | 1 |
| Miyake, H | 1 |
| Takenaka, H | 1 |
| Okano, A | 1 |
| Hirai, H | 1 |
| Shimazaki, C | 1 |
| Yasuno, H | 1 |
| Varma, S | 1 |
| Lanigan, SW | 1 |
| Sirieix, ME | 1 |
| Debure, C | 1 |
| Baudot, N | 1 |
| Dubertret, L | 1 |
| Roux, ME | 1 |
| Morel, P | 1 |
| Frances, C | 1 |
| Loubeyres, S | 1 |
| Beylot, C | 1 |
| Lambert, D | 1 |
| Humbert, P | 1 |
| Gauthier, O | 1 |
| Dandurand, M | 1 |
| Vaillant, L | 1 |
| Lorette, G | 1 |
| Bonnetblanc, JM | 1 |
| Lok, C | 1 |
| Denoeux, JP | 1 |
| Weinlich, G | 1 |
| Fritsch, P | 1 |
| Chowdhury, MM | 1 |
| Patel, GK | 1 |
| Inaloz, HS | 1 |
| Holt, PJ | 1 |
| de Montalembert, M | 1 |
| Bégué, P | 1 |
| Bernaudin, F | 1 |
| Thuret, I | 1 |
| Bachir, D | 1 |
| Micheau, M | 1 |
| Kirby, B | 1 |
| Gibson, LE | 1 |
| Rogers, S | 1 |
| Pittelkow, M | 1 |
| Schaefer, U | 1 |
| Micke, O | 1 |
| Schueller, P | 1 |
| Willich, N | 1 |
| Eming, SA | 1 |
| Peters, T | 1 |
| Hartmann, K | 1 |
| Scharffetter-Kochanek, K | 1 |
| Mahrle, G | 1 |
| Olesen, LH | 1 |
| Pedersen, BB | 1 |
| Kumar, B | 1 |
| Saraswat, A | 1 |
| Kaur, I | 1 |
| Lammintausta, K | 1 |
| Mäkelä, L | 1 |
| Remes, K | 1 |
| Renfro, L | 1 |
| Kamino, H | 1 |
| Raphael, B | 1 |
| Moy, J | 1 |
| Sanchez, M | 1 |
| Levantine, A | 1 |
| Almeyda, J | 1 |
| Ottolenghi, F | 1 |
| Andreassi, L | 1 |
| Hunter, GA | 1 |
| Simmons, IJ | 1 |
| Thomas, BM | 1 |
| Piver, MS | 1 |
| Barlow, JJ | 1 |
| Vongtama, V | 1 |
| Webester, J | 1 |
7 reviews available for hydroxyurea and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Hydroxyurea induced dermatomyositis-like eruption.
Topics: Aged; Anemia, Megaloblastic; Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Female; Humans; | 2012 |
Emerging adverse cutaneous drug reactions.
Topics: Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Agents; Drug Eruptions; Humans; Hydroxyurea; | 2012 |
Cutaneous reactions to chemotherapy drugs: the art of consultation.
Topics: Animals; Antineoplastic Agents; Bleomycin; Docetaxel; Doxorubicin; Drug Eruptions; Humans; Hydroxyur | 2003 |
Mucocutaneous side effects of antineoplastic chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Drug Eruptions; Hidradenitis; Humans; Hydroxyurea; Mucous Membrane; | 2004 |
Hydroxyurea-induced dermatomyositis-like eruption.
Topics: Aged; Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Female; Humans; Hydroxyurea; Male; Mid | 1995 |
[Osteitis secondary to toxic dermatitis caused by hydroxyurea. Apropos ofa case, review of the literature].
Topics: Aged; Drug Eruptions; Enzyme Inhibitors; Humans; Hydroxyurea; Male; Osteitis | 1995 |
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlor | 1974 |
2 trials available for hydroxyurea and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A clinical trial of hydroxyurea for psoriasis.
Topics: Adult; Aged; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Hydroxyurea; Male; Methotrexate; | 1972 |
Hydroxyurea and radiation therapy in advanced cervical cancer.
Topics: Anemia, Aplastic; Clinical Trials as Topic; Drug Eruptions; Drug Evaluation; Evaluation Studies as T | 1974 |
41 other studies available for hydroxyurea and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A Case of Thrombotic Vasculopathy in the Setting of High-Dose Hydroxyurea Use.
Topics: Aged; Debridement; Drug Eruptions; Humans; Hydroxyurea; Male; Skin; Thrombosis | 2021 |
Clinical Images: Hydroxyurea-induced dermatomyositis-like rash.
Topics: Dermatomyositis; Drug Eruptions; Exanthema; Humans; Hydroxyurea | 2022 |
Dermatomyositis-like eruption associated with hydroxyurea therapy: a premalignant condition?
Topics: Aged; Dermatomyositis; Diagnosis, Differential; Drug Eruptions; Drug Substitution; Erythema; Female; | 2014 |
Hydroxycarbamide-induced cutaneous ulceration with a difference.
Topics: Diagnosis, Differential; Drug Eruptions; Female; Hematinics; Humans; Hydroxyurea; Middle Aged; Prima | 2014 |
A Cutaneous Lupus Erythematosus-Like Eruption Induced by Hydroxyurea.
Topics: Adolescent; Drug Eruptions; Female; Humans; Hydroxyurea; Lupus Erythematosus, Cutaneous; Nucleic Aci | 2017 |
[Cutaneous side effects of hydroxyurea treatment for polycythemia vera].
Topics: Aged; Antisickling Agents; Carcinoma, Squamous Cell; Drug Eruptions; Female; Humans; Hydroxyurea; Le | 2009 |
Dermatomyositis-like eruption induced by hydroxyurea: a case report.
Topics: Aged; Dermatomyositis; Drug Eruptions; Hand Dermatoses; Humans; Hydroxyurea; Male; Nucleic Acid Synt | 2009 |
Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure.
Topics: Aged, 80 and over; Dermatomyositis; Diagnosis, Differential; DNA, Neoplasm; Drug Eruptions; Epidermi | 2010 |
Toenails melanonychia induced by hydroxyurea.
Topics: Aged; Antisickling Agents; Diagnosis, Differential; Drug Eruptions; Female; Humans; Hydroxyurea; Hyp | 2012 |
Toxicoderma caused by hydroxyurea.
Topics: Aged; Drug Eruptions; Female; Humans; Hydroxyurea; Nail Diseases; Pigmentation Disorders; Skin Ulcer | 2011 |
Scleroderma-like syndrome due to hydroxyurea.
Topics: Aged; Antineoplastic Agents; Drug Eruptions; Humans; Hydroxyurea; Leg Dermatoses; Male; Scleroderma, | 2012 |
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Carcinoma, Squamous Cell; Drug Eruptions; Female; F | 2012 |
Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption?
Topics: Aged; Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Female; Humans; Hydroxyurea; Leukemia, | 2012 |
Hydroxyurea-induced foot ulcer successfully treated with a topical basic fibroblast growth factor product.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Drug Eruptions; Fibroblast Growth Factors; Fo | 2003 |
Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment.
Topics: Age Factors; Aged; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cocarcinogenesis; Co | 2003 |
Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption.
Topics: Adolescent; Adult; Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Humans; Hydroxyurea; Leuk | 2003 |
Chronic penile ulceration in a 72-year-old man.
Topics: Aged; Antineoplastic Agents; Chronic Disease; Diagnosis, Differential; Drug Eruptions; Hand Dermatos | 2004 |
Gottron-like papules induced by hydroxyurea.
Topics: Aged; Drug Eruptions; Female; Hand Dermatoses; Humans; Hydroxyurea; Polycythemia Vera; Skin Diseases | 2005 |
Dermatomyositis-like eruption with long-term hydroxyurea.
Topics: Drug Administration Schedule; Drug Eruptions; Hand Dermatoses; Humans; Hydroxyurea; Male; Middle Age | 2006 |
Secondary cutaneous effects of hydroxyurea: possible pathogenetic mechanisms.
Topics: Aged; Arm; Diagnosis, Differential; Drug Eruptions; Humans; Hydroxyurea; Leg Ulcer; Male; Nucleic Ac | 2006 |
Photo-induced granulomatous eruption by hydroxyurea.
Topics: Diagnosis, Differential; Drug Eruptions; Female; Humans; Hydroxyurea; Middle Aged; Photosensitivity | 2007 |
[Cutaneous lesions induced by long-term use of hydroxyurea].
Topics: Aged; Drug Eruptions; Female; Humans; Hydroxyurea; Leukemia, Myeloid; Male; Middle Aged; Time Factor | 1984 |
Effects of hydroxyurea therapy on normal skin: a case report.
Topics: Adult; Drug Eruptions; Erythema; Humans; Hydroxyurea; Keratoderma, Palmoplantar; Male | 1980 |
Cutaneous manifestations of long-term hydroxyurea therapy.
Topics: Drug Eruptions; Humans; Hydroxyurea; Male; Middle Aged; Time Factors | 1994 |
Acute mucocutaneous toxicity following high-dose hydroxyurea.
Topics: Acute Disease; Adult; Drug Eruptions; Humans; Hydroxyurea; Male; Stomatitis | 1993 |
Pseudo-dermatomyositis induced by long-term hydroxyurea therapy: report of two cases.
Topics: Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Humans; Hydroxyurea; Male; Middle Aged | 1996 |
Chronic hydroxyurea-induced dermatomyositis-like eruption with severe dermal elastosis.
Topics: Antineoplastic Agents; Chronic Disease; Dermatomyositis; Drug Eruptions; Hand Dermatoses; Humans; Hy | 1998 |
Hydroxyurea dermopathy with a dermatomyositis-like eruption and a large leg ulcer.
Topics: Antineoplastic Agents; Drug Eruptions; Female; Hand Dermatoses; Humans; Hydroxyurea; Leg Ulcer; Leuk | 1998 |
Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis.
Topics: Aged; Aged, 80 and over; Dermatologic Agents; Dermatomyositis; Drug Eruptions; Female; Humans; Hydro | 1999 |
Leg ulcers and hydroxyurea: forty-one cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Eruptions; Female; Humans; Hydroxyurea; | 1999 |
Leg ulcers in patients treated with hydroxyurea for myeloproliferative disorders: what is the trigger?
Topics: Drug Eruptions; Humans; Hydroxyurea; Leg Ulcer; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nu | 1999 |
Hydroxyurea-induced skin disease mimicking the baboon syndrome.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Drug Eruptions; Enzyme Inhibitors; Exanthema; Fema | 1999 |
Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Child; Child, Preschool; Cohort Studies | 1999 |
Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis.
Topics: Drug Eruptions; Humans; Hydroxyurea; Leg Ulcer; Psoriasis | 2000 |
Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2000 |
Lichenoid chronic graft-versus-host disease-like acrodermatitis induced by hydroxyurea.
Topics: Acrodermatitis; Drug Eruptions; Enzyme Inhibitors; Graft vs Host Disease; Humans; Hydroxyurea; Liche | 2001 |
[Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
Topics: Aged; Antineoplastic Agents; Drug Eruptions; Female; Humans; Hydroxyurea; Leg Ulcer; Leukemia, Myelo | 2001 |
Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients.
Topics: Adult; Aged; Drug Eruptions; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydroxyurea; Icht | 2002 |
[A hydroxyurea-induced leg ulceration].
Topics: Antineoplastic Agents; Drug Eruptions; Female; Humans; Hydroxyurea; Leg Ulcer; Middle Aged; Polycyth | 2001 |
Ulcerative lichen planus-like dermatitis associated with hydroxyurea.
Topics: Drug Eruptions; Female; Hand Dermatoses; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-AB | 1991 |
[Limitations and risks of therapy of psoriasis with amethopterin and hydroxyurea].
Topics: Adult; Aged; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Chromosome Aberrat | 1971 |